Unternehmen Orion Biotech Opportunities Corp.
Aktien
A3CWEV
KYG6780C1096
ORIA
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 59 | 05.02.21 |
Chrystyna Stecyk
FOU | Founder | 61 | 05.02.21 |
Mark Kayal
DFI | Director of Finance/CFO | 39 | - |
Director/Board Member | 51 | - | |
Samuel Broder
BRD | Director/Board Member | 79 | - |
Corporate Officer/Principal | - | - | |
John Phelan
PRN | Corporate Officer/Principal | 60 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 59 | 05.02.21 |
Samuel Broder
BRD | Director/Board Member | 79 | - |
James Collins
BRD | Director/Board Member | 58 | - |
Director/Board Member | 51 | - | |
Louisa Rodriguez
BRD | Director/Board Member | 64 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 5 000 000 | 0 | 0 | 74,00 % |
Aktie B | 1 | 20 000 000 | 18 500 000 ( 92,50 %) | 0 |
Unternehmenskontakt
Orion Biotech Opportunities Corp.
One Vanderbilt Avenue 26th floor
10017, New York
+
http://www.orionbiotechopportunities.com![Straße Orion Biotech Opportunities Corp.(ORIA)](https://cdn.zonebourse.com/static/address/124414782.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+66,69 % | 5,54 Mrd. | |
+94,72 % | 1,23 Mrd. | |
+2,57 % | 986 Mio. | |
+32,46 % | 866 Mio. | |
+2,39 % | 668 Mio. | |
-0,36 % | 610 Mio. | |
-.--% | 600 Mio. | |
+10,28 % | 536 Mio. | |
-.--% | 500 Mio. |